» Articles » PMID: 34768873

Ex Vivo Human Colon Tissue Exposure to Pristine Graphene Activates Genes Involved in the Binding, Adhesion and Proliferation of Epithelial Cells

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Nov 13
PMID 34768873
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Toxicology studies on pristine graphene are limited and lack significant correlations with actual human response. The goal of the current study was to determine the response of total colonic human tissue to pristine graphene exposure. Biopsy punches of colon tissues from healthy human were used to assess the biological response after ex vivo exposure to graphene at three different concentrations (1, 10, and 100 µg/mL). mRNA expression of specific genes or intestinal cytokine abundance was assessed using real-time PCR or multiplex immunoassays, respectively. Pristine graphene-activated genes that are related to binding and adhesion ( and ) within 2 h of exposure. Furthermore, the (proliferating cell nuclear antigen) gene was upregulated after exposure to graphene at all concentrations. Ingenuity pathway analysis revealed that STAT3 and VEGF signaling pathways (known to be involved in cell proliferation and growth) were upregulated. Graphene exposure (10 µg/mL) for 24 h significantly increased levels of pro-inflammatory cytokines IFNγ, IL-8, IL-17, IL-6, IL-9, MIP-1α, and Eotaxin. Collectively, these results indicated that graphene may activate the STAT3-IL23-IL17 response axis. The findings in this study provide information on toxicity evaluation using a human-relevant ex vivo colon model and serve as a basis for further exploration of its bio-applications.

Citing Articles

Environmental and Health Impacts of Graphene and Other Two-Dimensional Materials: A Graphene Flagship Perspective.

Lin H, Buerki-Thurnherr T, Kaur J, Wick P, Pelin M, Tubaro A ACS Nano. 2024; 18(8):6038-6094.

PMID: 38350010 PMC: 10906101. DOI: 10.1021/acsnano.3c09699.


Ginsenoside Rg3 Reduces the Toxicity of Graphene Oxide Used for pH-Responsive Delivery of Doxorubicin to Liver and Breast Cancer Cells.

Rahimi S, van Leeuwen D, Roshanzamir F, Pandit S, Shi L, Sasanian N Pharmaceutics. 2023; 15(2).

PMID: 36839713 PMC: 9965446. DOI: 10.3390/pharmaceutics15020391.


Carbon nanostructures: a comprehensive review of potential applications and toxic effects.

Farmand M, Jahanpeyma F, Gholaminejad A, Azimzadeh M, Malaei F, Shoaie N 3 Biotech. 2022; 12(8):159.

PMID: 35814038 PMC: 9259781. DOI: 10.1007/s13205-022-03175-6.

References
1.
Fadeel B, Bussy C, Merino S, Vazquez E, Flahaut E, Mouchet F . Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment. ACS Nano. 2018; 12(11):10582-10620. DOI: 10.1021/acsnano.8b04758. View

2.
Howe C, Kim S, Mitchell J, Im E, Kim Y, Kim Y . Differential expression of tumor-associated genes and altered gut microbiome with decreased Akkermansia muciniphila confer a tumor-preventive microenvironment in intestinal epithelial Pten-deficient mice. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(12):3746-3758. PMC: 6239937. DOI: 10.1016/j.bbadis.2018.10.006. View

3.
Kubben F, Engels L, Baeten C, Schutte B, Arends J, Stockbrugger R . Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut. 1994; 35(4):530-5. PMC: 1374804. DOI: 10.1136/gut.35.4.530. View

4.
Ruiz O, Fernando K, Wang B, Brown N, Luo P, McNamara N . Graphene oxide: a nonspecific enhancer of cellular growth. ACS Nano. 2011; 5(10):8100-7. DOI: 10.1021/nn202699t. View

5.
Mukherjee A, Majumdar S, Servin A, Pagano L, Dhankher O, White J . Carbon Nanomaterials in Agriculture: A Critical Review. Front Plant Sci. 2016; 7:172. PMC: 4762280. DOI: 10.3389/fpls.2016.00172. View